Genitourinary Cancers | Tumor

July GU Cancer Highlights: Top 5 Updates Patients Should Know

July 31st 2025, 5:00pm

Article

As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.

Rapid Developments to Enhance Patient Experience in GU Cancer

May 30th 2025, 9:00pm

Article

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.

What I Learned From My Cancer Nurse Maria

May 25th 2025, 2:00pm

Article

Maria, my oncology nurse, inspired lasting change in my life through compassion, wisdom and faith during my cancer surgery and recovery.

FDA Approves Zynyz Treatment Regimen for Advanced Anal Cancer

May 15th 2025, 7:27pm

Article

The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer.

Renewal and Healing from Testicular Cancer This May

May 2nd 2025, 5:00pm

Article

After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise this spring.

Springtime Health After My Testicular Cancer Diagnosis

April 14th 2025, 5:00pm

Article

Experiencing spring's renewal after a cancer diagnosis, I focus on health through checkups, diet and exercise, embracing change and well-being.

Early Detection Critical for Testicular Cancer in Young Men

April 14th 2025, 1:02pm

Video

April serves as Testicular Cancer Awareness Month, which is the most common type of cancer in men aged between 15 and 44 years old.

Knowing the Signs to Detect and Treat Testicular Cancer Early

April 11th 2025, 7:00pm

Article

Testicular cancer is rare but highly curable, especially with early detection; treatment varies by stage, and follow-up care supports long-term health.

What Patients With Kidney Cancer Need to Know From ASCO GU

March 30th 2025, 2:00pm

Article

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Top 3 Takeaways From ASCO GU 2025

March 25th 2025, 8:16pm

Video

Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.